Vanda Pharmaceuticals Inc. (LON:0LKB)

Vanda Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	355	223	191	347	646	526
Market Cap Growth	55.73%	17.04%	-45.08%	-46.23%	22.64%	-20.35%
Enterprise Value	145	-71	-186	-21	355	281
Last Close Price	6.03	3.76	3.31	6.05	12.70	9.05
PE Ratio	-	-	96.77	66.65	26.37	30.79
PS Ratio	2.25	1.41	1.26	1.64	3.25	2.90
PB Ratio	1.02	0.52	0.45	0.79	1.73	1.59
P/TBV Ratio	1.34	0.66	0.57	0.82	1.80	1.67
P/FCF Ratio	-	-	-	13.36	13.73	14.38
P/OCF Ratio	-	-	18.97	13.08	13.61	13.88
EV/Sales Ratio	0.92	-	-	-	1.79	1.55
EV/EBITDA Ratio	-	-	-	-	10.69	12.74
EV/EBIT Ratio	-	-	-	-	11.41	14.08
EV/FCF Ratio	-2.35	-	-	-	7.55	7.68
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.02	0.03
Debt / EBITDA Ratio	-	-	-	0.95	0.26	0.42
Debt / FCF Ratio	-	-	-	0.36	0.19	0.27
Asset Turnover	0.34	0.31	0.30	0.41	0.48	0.49
Inventory Turnover	6.46	7.34	11.60	21.89	22.24	19.31
Quick Ratio	2.92	4.22	4.82	5.47	6.25	6.03
Current Ratio	3.12	4.39	4.94	5.68	6.43	6.21
Return on Equity (ROE)	-16.72%	-3.49%	0.47%	1.22%	6.92%	5.40%
Return on Assets (ROA)	-12.15%	-3.90%	-1.36%	0.64%	4.68%	3.35%
Return on Invested Capital (ROIC)	-68.11%	-23.76%	-4.65%	4.51%	35.94%	18.89%
Return on Capital Employed (ROCE)	-25.10%	-7.30%	-2.50%	1.20%	8.10%	5.80%
Earnings Yield	-17.66%	-6.77%	1.03%	1.50%	3.79%	3.25%
FCF Yield	-17.40%	-7.33%	-36.35%	7.49%	7.28%	6.96%
Buyback Yield / Dilution	-1.34%	-1.03%	-1.01%	-0.11%	-3.14%	-0.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.